Six Drugs To Watch In 2005

Big pharmaceutical companies might be in a slump, but some of their research laboratories aren't. And, as ever, small biotechnology companies are gambling everything on products that could either become miracle cures or duds. Month in, month out, our list of New Drugs To Watch helps sort out some of the noteworthy medicines in human trials. This month, we've added six new medicines to our database of more than three dozen experimental drugs. Among them are potential treatments for Alzheimer's disease, skin cancer and rheumatoid arthritis. The drug developers include Bristol-Myers Squibb (nyse: BMY - news - people ), which has two new additions, as well as Pfizer (nyse: PFE - news - people ) and Wyeth (nyse: WYE - news - people ), but tiny biotechs also make their presence felt. All of them face long odds--most drugs that make it into clinical testing still don't reach the market. More...

Back to news